Driving Precision Medicine Through Innovation in Proteomics

Drug Development

We design, perform and interpret high resolution proteomics studies to improve target discovery, validation and mechanism of action studies.

Learn More

Biomarker Discovery

Combined tissue and fluid proteomics delivers superior discovery and validation of diagnostic, stratification and pharmacodynamic biomakers.

Learn More

Data Insight

A suite of highly evolved statistical and functional analysis tools ensuring you receive knowledge, not just data.

Learn More

New!

Appointment of Chief Executive Officer. Dr. Mariola Söhngen has been appointed as a director and Chief Executive Officer. CEO appointment

TMT® used in ground breaking research in COVID-19 - Dr. Christian Münch Webinar

Protein Research Bulletin

Prof. Steve Gygi's review of TMTpro™. Read more

For Clinical Trial Samples – Scientist.com recently qualified our SRM and TMT-SRM assays as being fit-for-purpose under GCLP accreditation.

New report on growing opportunities for TMT: “Tandem Mass Tag Usage Could Benefit From New Methods, Expanded Applications” available to premium subscribers of GenomeWeb Link here

Landmark paper on Alzheimer's disease molecular pathology published Read more